A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers

Clinical trial NCT07299955 · RECRUITING

Trial details

NCT number: NCT07299955
Sponsor: Biocon Biologics UK PLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Participants

Start date: 2026-02-28
Primary completion: 2026-06-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.